PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-04-05

Date Title Company
05-Apr-2023 Farallon Issues Letter to Exelixis Board of Directors Outlining Case for Change Businesswire
05-Apr-2023 Beckley Psytech initiates Phase IIa study of 5-MeO-DMT candidate BPL-003 for Alcohol Use Disorder Businesswire
05-Apr-2023 bioAffinity Technologies to Ring Nasdaq Closing Bell Today Businesswire
05-Apr-2023 Exegenesis Bio To Present Five Posters at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting, Los Angeles, CA, May 16-20, 2023 Businesswire
05-Apr-2023 York Private Equity-Backed APT Healthcare Announces Expansion of Physical Therapy Practice into Southeastern and Mid-Atlantic U.S. Regions APT Healthcare
05-Apr-2023 BELLUS Health Announces Positive Results from its Phase 1 Bioavailability Equivalence Study Evaluating Once-Daily Extended-Release Formulation of Camlipixant in Comparison to Twice-Daily Immediate Release Formulation Businesswire
05-Apr-2023 Enanta Pharmaceuticals to Present Data at the 33rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) Businesswire
05-Apr-2023 Global Rare Disease Therapeutics Market Report 2023: Players Include AbbVie, Novo Nordisk, Sanofi, Bayer, Amgen and Eisai - ResearchAndMarkets.com Businesswire
05-Apr-2023 Endogena Therapeutics Completes Dose Escalation in the Phase 1/2a Clinical Trial of EA-2353 for the Treatment of Retinitis Pigmentosa Endogena Therapeutics
05-Apr-2023 CluePoints Announces Amit Patel as New CFO CluePoints
05-Apr-2023 Global Gel Documentation Systems Market to 2028: Growing demand for Advanced Techniques Fuels the Sector - ResearchAndMarkets.com Businesswire
05-Apr-2023 Notice of General Meeting and Publication of Circular OKYO Pharma Limited
05-Apr-2023 BenevolentAI announces top-line Phase IIa results for its topical pan-Trk inhibitor BEN-2293 (1%) in mild-to-moderate atopic dermatitis BenevolentAI
05-Apr-2023 GlobalData Publishes FDA Regulatory Guidance and Strategy Report for Biotech Approval Pathways Novotech
05-Apr-2023 Greenphire Appoints Steve Geffon as Chief Commercial Officer Greenphire
05-Apr-2023 Innovative first in class HSF1 pathway cancer drug shows strong results in new study The Institute of Cancer Research, London
05-Apr-2023 Next Generation Immunotherapies Market is expected to reach a valuation of US$ 268.84 billion by 2033 | FMI Study MARKITWIRED
05-Apr-2023 TNG Creative Wins Two Prestigious Awards for an Integrated Marketing Campaign Newswire
05-Apr-2023 Synthace, a Digital Experiment Platform for Life Science R&D, Records Strongest Year Yet Businesswire
05-Apr-2023 Endometrial Ablation Market in the United Kingdom is projected to expand at a CAGR of around 8.4% from 2023 to 2033 | FMI MARKITWIRED